Seosaph Introduces PortiVix, Expanding the Future of Pharma Project & Portfolio Management

Bengaluru, India - Seosaph announces the launch of PortiVix, the next evolution of its Pharma Project & Portfolio Management platform. As part of the launch of VirtuNx, Seosaph's dedicated enterprise product organization, its flagship Pharma PPM platform SEOPRO has evolved into PortiVix, reflecting a broader vision for intelligent decision-making and the future of pharmaceutical portfolio management.

Built on the foundation established by SEOPRO, PortiVix represents an expanded vision for pharmaceutical organizations navigating increasingly complex R&D programs, evolving regulatory requirements and rapidly changing portfolio priorities.

While SEOPRO helped organizations strengthen project execution and governance, PortiVix broadens that vision by bringing together project execution, portfolio oversight, strategic prioritization, governance, and decision intelligence within one connected platform.

Already adopted by leading pharmaceutical organizations, the platform's evolution has been driven by continuous customer engagement, emerging industry needs, and Seosaph's commitment to building enterprise technology that evolves alongside the businesses it serves.

"Innovation is not about changing what works; it's about expanding what's possible," said Nagarajan Selvaraj, CEO, Seosaph.

"PortiVix reflects our long-term vision of helping pharmaceutical organizations navigate increasing complexity with greater intelligence, confidence, and agility. As the industry evolves, enterprise technology must evolve with it."

The evolution of PortiVix has been shaped through the combined strengths of enterprise technology, pharmaceutical domain expertise, and close collaboration with customers.

"SEOPRO laid the foundation. PortiVix expands that vision," said Phanindra Venkata, CEO, VirtuNx & Business Head, Seosaph.

"Our goal was never to build another project management platform. It was to create a connected ecosystem that enables organizations to move beyond execution towards better portfolio decisions. PortiVix is the realization of that vision."

Designed specifically for the realities of pharmaceutical organizations, PortiVix addresses the growing need for greater visibility across projects, portfolios, governance, resources, and strategic priorities.

"The pharmaceutical industry demands more than efficient project management. It demands confidence in every decision," said Ashwini Shrivastava, Product Head, PortiVix.

"PortiVix has been designed around the way pharmaceutical organizations actually work, helping teams simplify complexity, strengthen governance, and make informed decisions throughout the portfolio lifecycle."

With PortiVix, Seosaph continues its mission of building intelligent enterprise platforms that transform complexity into clarity and data into confident action.

PortiVix
Built to Go Beyond.

About Seosaph

Seosaph is an enterprise technology company delivering AI, cloud, data engineering and digital transformation solutions for regulated and data-intensive industries. Trusted by Fortune 500 companies and global enterprises, Seosaph helps organizations accelerate execution and achieve measurable business outcomes. Its enterprise product organization, VirtuNx, develops intelligent software platforms that empower organizations to make better decisions with greater speed and confidence.

About PortiVix

PortiVix is Seosaph's intelligent Pharma Project & Portfolio Management platform, purpose-built to help pharmaceutical organizations connect projects, portfolios, governance, and decision-making within a unified ecosystem. Evolved from Seopro, PortiVix represents the next generation of intelligent project and portfolio management for the pharmaceutical industry.